Chinese herbal medicine for functional dyspepsia: systematic review of systematic reviews

Author:

Chu Michael H. K.1,Wu Irene X. Y.2,Ho Robin S. T.3,Wong Charlene H. L.4,Zhang Anthony L.5,Zhang Yan6,Wu Justin C. Y.7,Chung Vincent C. H.8

Affiliation:

1. Global Physician-Leadership Stream, MBChB program, The Chinese University of Hong Kong, Hong Kong

2. Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, 5/F, School of Public Health Building, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

3. Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong

4. Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong

5. China–Australia International Research Centre for Chinese Medicine School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Sydney, Australia

6. Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Sydney, Australia Department of Family and Community Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA

7. Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong

8. Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong

Abstract

Background: Pharmacotherapy, including prokinetics and proton pump inhibitors for functional dyspepsia (FD) have limited effectiveness, and their safety has been recently questioned. Chinese herbal medicine (CHM) could be considered as an alternative. A systematic review (SR) of SRs was performed to evaluate the potential effectiveness and safety of CHM. Method: We conducted a comprehensive literature search for SRs with meta-analyses in eight international and Chinese databases. Pooled effect estimation from each meta-analysis was extracted. The AMSTAR instrument was used to assess the methodological quality of the included SRs. Results: A total of 14 SRs of mediocre quality assessing various CHMs, alone or in combination with conventional pharmacotherapy, were included. Meta-analyses showed that CHM was more effective than prokinetic agents for the alleviation of global dyspeptic symptoms. Three specific CHM formulae appeared to show superior results in the alleviation of global dyspeptic symptoms, including Si Ni San, modified Xiao Yao San and Xiang Sha Liu Jun Zi decoction. No significant difference in the occurrence of adverse events in using CHM or pharmacotherapy was reported. Conclusion: CHM can be considered as an alternative for the treatment of FD symptoms when prokinetic agents and proton pump inhibitors are contraindicated. Future trial design should focus on measuring changes in individual dyspeptic symptoms and differentiate the effectiveness of different CHM for postprandial distress syndrome and epigastric pain syndrome. A network meta-analysis approach should be used to explore the most promising CHM formula for FD treatment in the future.

Publisher

SAGE Publications

Subject

Gastroenterology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3